Internal Medicine · Bayamon, PR
NPI
1760562433
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
Bayamon Medical Mall, Suite 709
Bayamon, PR, 00959
Phone (787) 919-7855
Medicare paid, 2024
$17K
265 services
Medicare patients, 2024
60
Average age 79
Drug cost, 2024
$2.9M
30,701 prescriptions
Company payments, 2025
$232
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Norbert Correa Sardina was code 99232 (hospital e&m - subsequent), 173 times for 39 patients. In total Norbert Correa Sardina billed 265 services in 8 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 173 | 39 | $60.46 | $10K |
| 99238 Hospital Discharge Management | Facility | 32 | 31 | $62.70 | $2,006 |
| 99213 Office E&M - Established | Office | 31 | 16 | $53.25 | $1,651 |
| 99223 Hospital E&M - Initial | Facility | 23 | 23 | $113.88 | $2,619 |
By year: 2022 $30K for 443 services; 2023 $38K for 540 services; 2024 $17K for 265 services.
Medicare prescription drug claims, 2024
In 2024, the drug Norbert Correa Sardina prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,642 prescriptions and refills. In total Norbert Correa Sardina wrote 30,701 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,642 | 4,430 | 583 | $22K |
| Gabapentin Generic | 1,343 | 3,066 | 394 | $28K |
| Rosuvastatin Calcium Generic | 1,181 | 3,361 | 390 | $20K |
| Losartan Potassium Generic | 1,049 | 2,925 | 350 | $14K |
| Levothyroxine Sodium Generic | 882 | 2,449 | 274 | $16K |
| Amlodipine Besylate Generic | 868 | 2,398 | 301 | $5,341 |
| Metoprolol Succinate Generic | 817 | 2,116 | 314 | $16K |
| Synthroid Levothyroxine Sodium | 794 | 1,963 | 218 | $89K |
| Famotidine Generic | 793 | 1,455 | 296 | $6,755 |
| Metformin Hcl Generic | 786 | 2,172 | 257 | $6,826 |
| Pantoprazole Sodium Generic | 703 | 1,349 | 239 | $8,920 |
| Montelukast Sodium Generic | 681 | 1,132 | 399 | $7,548 |
| Omeprazole Generic | 608 | 1,158 | 162 | $6,747 |
| Lisinopril Generic | 599 | 1,677 | 196 | $5,127 |
| Omega-3 Acid Ethyl Esters Generic | 566 | 920 | 137 | $38K |
Brand drugs: 4,512 claims; generic drugs: 25,927 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Norbert Correa Sardina $232 ($232 in general payments such as food, travel and fees) from 3 companies. The largest payer was Terumo Medical Corporation with $117.
| Company | Payments | Amount |
|---|---|---|
| Terumo Medical Corporation | 1 | $117 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $72.55 |
| Pbg Puerto Rico LLC | 2 | $42.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.